Picroside II prevents inflammation injury in mice with diabetic nephropathy via TLR4/NF-κB pathway

Main Article Content

Chunmei Ma
Aijie Shi


picroside II, inflammation injury, diabetic nephropathy, TLR4/NF-κB pathway


The purpose of this study was to investigate the therapeutic effects of picroside II on diabetic nephropathy and reveal the involved underlying signal pathway. Male Sprague–Dawley (SD) mice were used to construct an animal model of streptozotocin (STZ)-induced diabetic nephropathy. Body weight and fasting blood glucose values were recorded. Enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of proteinuria, blood urea nitrogen (BUN), serum creatinine (Scr), interleukin (IL)-1β, IL-6, monocyte chemoattractant protein-1 (MCP-1) and necrosis factor alpha (TNF-α). Protein expression was determined using Western blotting test. Hematoxylin and eosin (H&E) staining was used to examine the morphological changes in kidney tissues. Treatment with picroside II (10 and 20 mg/kg) increased the STZ-induced reduction in body weight of diabetic mice. It also reversed the elevation of fasting blood glucose in STZ-induced diabetic mice. The levels of proteinuria, BUN and Scr were significantly increased in STZ-induced diabetic mice and these increments were prevented by picroside II. The serum levels of MCP-1, IL-1β, IL-6 and TNF-α were reduced, and the morphological damage was lessened by Picroside II in mice with diabetic nephropathy. Besides, picroside II prevented the activation of TLR4/NF-κB pathway. This study proved that picroside II inhibited inflammatory response and prevented kidney injury in mice with diabetic nephropathy through modulation of TLR4/NF-κB pathway, indicating beneficial effect of picroside II on diabetic nephropathy.

Abstract 231 | PDF Downloads 85 HTML Downloads 57 XML Downloads 52


Cai, Y., Zhang, Y., Chen, H., Sun, X.H., Zhang, P., Zhang, L., et al. 2021. MicroRNA-17-3p suppresses NF-κB-mediated endothelial inflammation by targeting NIK and IKKβ binding protein. Acta Pharmacologica Sinica 2021 Feb 23 10.1038/s41401-021-00611-w

Choi, J., Choi, B.K., Kim, J.S., Lee, J.W., Park, H.A., Ryu, H.W., et al. 2016. Picroside II attenuates airway inflammation by downregulating the transcription factor GATA3 and Th2-related cytokines in a mouse model of HDM-induced allergic asthma. PLoS One 11: e0167098. 10.1371/journal.pone.0167098

John, S., 2016. Complication in diabetic nephropathy. Diabetes and Metabolic Syndrome 10: 247–249. 10.1016/j.dsx.2016.06.005

Kintu, A., Abdulla, S., Lubikire, A., Nabukenya, M.T., Igaga, E., Bulamba, F., et al. 2019. Postoperative pain after cesarean section: assessment and management in a tertiary hospital in a low-income country. BMC Health Serv Res. 19(1): 68. 10.1186/s12913-019-3911-x

Kitada, M., Ogura, Y. and Koya, D., 2016. Rodent models of diabetic nephropathy: their utility and limitations. International Journal of Nephrology and Renovascular Disease 9: 279–290. 10.2147/ijnrd.S103784

Lee, K., Choi, J., Choi, B.K., Gu, Y.M., Ryu, H.W., Oh, S.R., et al. 2019. Picroside II isolated from pseudolysimachion rotundum var. subintegrum inhibits glucocorticoid refractory serum amyloid A (SAA) expression and SAA-induced IL-33 secretion. Molecules 24. 10.3390/molecules24102020

National Research Council of the National Academies, 2011. Committee for the update of the guide for the care and use of laboratory animals. In: Guide for the care and use of laboratory animals, 8th edition. The National Academies collection: reports funded by National Institutes of Health. The National Academies Press, Washington, DC.

Ni, W.W., Zhang, Q.M., Zhang, X., Li, Y., Yu, S.s., Wu, H.y., et al. 2020. Modulation effect of Lactobacillus acidophilus KLDS 1.0738 on gut microbiota and TLR4 expression in β-lactoglobulin-induced allergic mice model. Allergologia et Immunopathologia 48: 149–157. 10.1016/j.aller.2019.06.002

Qi, C., Mao, X., Zhang, Z. and Wu, H., 2017. Classification and differential diagnosis of diabetic nephropathy. Journal of Diabetes Research 2017: 8637138. 10.1155/2017/8637138

Tervaert, T.W., Mooyaart, A.L., Amann, K., Cohen, A.H., Cook, H.T., Drachenberg, C.B., et al. 2010. Pathologic classification of diabetic nephropathy. Journal of the American Society of Nephrology (JASN) 21: 556–563. 10.1681/asn.2010010010

Umanath, K. and Lewis, J.B., 2018. Update on diabetic nephropathy: core curriculum 2018. American Journal of Kidney Diseases (AJKD) 71: 884–895. 10.1053/j.ajkd.2017.10.026

Wada, J. and Makino, H., 2013. Inflammation and the pathogenesis of diabetic nephropathy. Clinical Science (London) 124: 139–152. 10.1042/cs20120198

Wang, L., Liu, X.H., Chen, H., Chen, Z.Y., Weng, X.D., Qiu, T., et al. 2015. Picroside II protects rat kidney against ischemia/reperfusion-induced oxidative stress and inflammation by the TLR4/NF-κB pathway. Experimental and Therapeutic Medicine 9: 1253–1258. 10.3892/etm.2015.2225

Xiong, Y. and Zhou, L., 2019. The signaling of cellular senescence in diabetic nephropathy. Oxidative Medicine and Cellular Longevity 2019: 7495629. 10.1155/2019/7495629

Yang, S., Zhang, J., Wang, S., Zhao, X. and Shi, J., 2017. SOCS2 overexpression alleviates diabetic nephropathy in rats by inhibiting the TLR4/NF-κB pathway. Oncotarget 8: 91185–91198. 10.18632/oncotarget.20434

Zusso, M., Lunardi, V., Franceschini, D., Pagetta, A., Lo, R., Stifani, S., et al. 2019. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway. Journal of Neuroinflammation 16: 148. 10.1186/s12974-019-1538-9